论文信息 - Updated Data of a Phase 1/2 Study (AF-001JP) of Alectinib, a CNS-Penetrant, Highly Selective ALK Inhibitor in ALK-rearranged Advanced NSCLC - 字舞流文

Updated Data of a Phase 1/2 Study (AF-001JP) of Alectinib, a CNS-Penetrant, Highly Selective ALK Inhibitor in ALK-rearranged Advanced NSCLC

Y. Ohe | K. Kikuchi | M. Maemondo | M. Nishio | H. Murakami | T. Seto | T. Tamura | T. Hida | N. Nogami | H. Yoshioka | T. Asakawa | A. Inoue | M. Harada | K. Takeuchi | Tomohiro Tanaka | K. Nakagawa | M. Harada | N. Nogami